Endothelial dysfunction and renal fibrosis in endotoxemia-induced oliguric kidney injury: Possible role of LPS-binding protein

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Castellano, Giuseppe ^a   Stasi, Alessandra ^a   Intini, Angelica ^a   Gigante, Margherita ^a   Di Palma, Anna Maria ^a   Divella, Chiara ^a   Netti, Giuseppe Stefano ^b   Prattichizzo, Clelia ^b   Pontrelli, Paola ^a   Crovace, Antonio ^a   Staffieri, Francesco ^a   Fiaccadori, Enrico ^c   Brienza, Nicola ^a   Grandaliano, Giuseppe ^b   Pertosa, Giovanni ^a   Gesualdo, Loreto ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; CITRIC ACID; COLLAGEN TYPE 1; KI 67 ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; VIMENTIN; ACUTE PHASE PROTEIN; CARRIER PROTEIN; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD FILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; COUPLED PLASMA FILTRATION ADSORPTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY INJURY; LIPOPOLYSACCHARIDE-INDUCED ENDOTOXEMIA; NONHUMAN; OLIGURIA; PIG; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; RNA SYNTHESIS; ACUTE KIDNEY FAILURE; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; FIBROSIS; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; ANIMALS; CARRIER PROTEINS; CASPASE 3; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; KIDNEY; MEMBRANE GLYCOPROTEINS; SWINE;

EID: 84988693322     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0520-2     Document Type: Article

References (47)

1. Ronco C, Brendolan A, Dan M, Piccinni P, Bellomo R, De Nitti C, Inguaggiato P, Tetta C: Adsorption in sepsis. Kidney Int Suppl 2000, 76:S148-S155.
2. Zarjou A, Agarwal A: Sepsis and acute kidney injury. J Am Soc Nephrol 2011, 22:999-1006.
3. Ramnath RD, Ng SW, Guglielmotti A, Bhatia M: Role of MCP-1 in endotoxemia and sepsis. Int Immunopharmacol 2008, 8:810-818.
4. Wu L, Gokden N, Mayeux PR: Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury. J Am Soc Nephrol 2007, 18:1807-1815.
5. Patschan D, Patschan S, Muller GA: Endothelial progenitor cells in acute ischemic kidney injury: strategies for increasing the cells' renoprotective competence. Int J Nephrol 2011, 2011:828369.
6. Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C: Progression of renal fibrosis: the underestimated role of endothelial alterations. Fibrogenesis Tissue Repair 2012, 5:S15.
7. Basile DP: The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007, 72:151-156.
8. Rabelink TJ, de Boer HC, van Zonneveld AJ: Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol 2010, 6:404-414.
9. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011, 121:4210-4221.
10. Dunzendorfer S, Lee HK, Soldau K, Tobias PS: Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J 2004, 18:1117-1119.
11. Bussolati B, David S, Cambi V, Tobias PS, Camussi G: Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS. Int J Mol Med 2002, 10:441-449.
12. Singla S, Predescu D, Bardita C, Wang M, Zhang J, Balk RA, Predescu S: Pro-inflammatory endothelial cell dysfunction is associated with intersectin-1 s down-regulation. Respir Res 2011, 12:46.
13. Lee SY, Lee YS, Choi HM, Ko YS, Lee HY, Jo SK, Cho WY, Kim HK: Distinct pathophysiologic mechanisms of septic acute kidney injury: role of immune suppression and renal tubular cell apoptosis in murine model of septic acute kidney injury. Crit Care Med 2012, 40:2997-3006.
14. Morgera S, Klonower D, Rocktaschel J, Haase M, Priem F, Ziemer S, Wegner B, Gohl H, Neumayer HH: TNF-elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transplant 2003, 18:1361-1369.
15. Pozzato M: Citrate: an additional resource for anticoagulation in continuous replacement therapy. G Ital Nefrol 2012, 29:20-26.
16. Sessler CN, Shepherd W: New concepts in sepsis. Curr Opin Crit Care 2002, 8:465-472.
17. Ronco C, Kellum JA, Bellomo R, House AA: Potential interventions in sepsis-related acute kidney injury. Clin J Am Soc Nephrol 2008, 3:531-544.
18. Rimmele T, Kellum JA: Clinical review: blood purification for sepsis. Crit Care 2011, 15:205.
19. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351:159-169.
20. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, Mauri D, Burns K, Riederer BM, Akira S, Calandra T: Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci U S A 2009, 106:2348-2352.
21. Doi K, Leelahavanichkul A, Yuen PS, Star RA: Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest 2009, 119:2868-2878.
22. Echeverria C, Montorfano I, Sarmiento D, Becerra A, Nunez-Villena F, Figueroa XF, Cabello-Verrugio C, Elorza AA, Riedel C, Simon F: Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells. J Cell MolMed 2013, 17:800-814.
23. Kizu A, Medici D, Kalluri R: Endothelial-mesenchymal transition as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am J Pathol 2009, 175:1371-1373.
24. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R: Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013, 19:1047-1053.
25. Dauphinee SM, Karsan A: Lipopolysaccharide signaling in endothelial cells. Lab Invest 2006, 86:9-22.
26. Lerolle N, Nochy D, Guerot E, Bruneval P, Fagon JY, Diehl JL, Hill G: Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 2010, 36:471-478.
27. Wong F, Hull C, Zhande R, Law J, Karsan A: Lipopolysaccharide initiates a TRAF6-mediated endothelial survival signal. Blood 2004, 103:4520-4526.
28. Sato T, Kamiyama Y, Jones RT, Cowley RA, Trump BF: Ultrastructural study on kidney cell injury following various types of shock in 26 immediate autopsy patients. Adv Shock Res 1978, 1:55-69.
29. Curci C, Castellano G, Stasi A, Divella C, Loverre A, Gigante M, Simone S, Cariello M, Montinaro V, Lucarelli G, Ditonno P, Battaglia M, Crovace A, Staffieri F, Oortwijn B, van Amersfoort E, Gesualdo L, Grandaliano G: Endothelial-to-mesenchymal transition and renal fibrosis in ischaemia/reperfusion injury are mediated by complement anaphylatoxins and Akt pathway. Nephrol Dial Transplant 2014, 29:799-808.
30. Kisseleva T, Brenner DA: Mechanisms of fibrogenesis. Exp Biol Med 2008, 233:109-122.
31. Tapping RI, Akashi S, Miyake K, Godowski PJ, Tobias PS: Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000, 165:5780-5787.
32. Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, Rink RR, Meldrum KK: Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J Surg Res 2011, 168:e61-e69.
33. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD: Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000, 31:1491-1497.
34. Gerthoffer WT, Singer CA: Secretory functions of smooth muscle: cytokines and growth factors. Mol Interv 2002, 2:447-456.
35. Aziz M, Jacob A, Yang WL, Matsuda A, Wang P: Current trends in inflammatory and immunomodulatory mediators in sepsis. J Leukoc Biol 2013, 93:329-342.
36. Webster NR, Galley HF: Immunomodulation in the critically ill. Br J Anaesth 2009, 103:70-81.
37. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002, 30:1250-1255.
38. Oudemans-van Straaten HM, Ostermann M: Bench-to-bedside review: citrate for continuous renal replacement therapy, from science to practice. Crit Care 2012, 16:249.
39. Bryland A, Wieslander A, Carlsson O, Hellmark T, Godaly G: Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions. Diab Vasc Dis Res 2012, 9:42-51.
40. Fenton MJ, Golenbock DT: LPS-binding proteins and receptors. J Leukoc Biol 1998, 64:25-32.
41. Triantafilou M, Triantafilou K: Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol 2002, 23:301-304.
42. Pugin J, Stern-Voeffray S, Daubeuf B, Matthay MA, Elson G, Dunn-Siegrist I: Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 2004, 104:4071-4079.
43. Jerala R: Structural biology of the LPS recognition. Int J Med Microbiol 2007, 297:353-363.
44. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, Remick DG, Wang SC: Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and Toll-like receptor 4. Hepatology 2000, 31:932-936.
45. Mueller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U: Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol 2005, 174:1091-1096.
46. Park BS, Lee JO: Recognition of lipopolysaccharide pattern by TLR4 complexes. Exp Mol Med 2013, 45:e66.
47. Heinzelmann M, Bosshart H: Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes. J Immunol 2005, 174:2280-2287.